Equity
AOCI
Bristol-Myers Squibb AOCI increased by 2.6% to -$1.51B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from -$1.47B to -$1.51B. Over 4 years (FY 2020 to FY 2024), AOCI shows an upward trend with a -9.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large negative values often reflect unfavorable currency movements or a decline in the market value of the company's investment portfolio.
Detailed definition
A component of equity that aggregates unrealized gains and losses that are excluded from net income. This typically incl...
Peer comparison
Multinational corporations with significant overseas operations and large cash portfolios are more sensitive to this metric than domestic-only firms.
Metric ID:
aociHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.52B | -$1.42B | -$1.27B | -$1.23B | -$992.00M | -$841.00M | -$1.28B | -$1.37B | -$1.39B | -$1.29B | -$1.55B | -$1.40B | -$1.46B | -$1.47B | -$1.24B | -$1.42B | -$1.55B | -$1.51B |
| QoQ Change | — | +6.2% | +11.0% | +3.1% | +19.3% | +15.2% | -52.3% | -6.8% | -1.4% | +7.3% | -20.2% | +9.4% | -4.0% | -0.8% | +15.7% | -15.0% | -9.1% | +2.6% |
| YoY Change | — | — | — | — | +34.7% | +40.9% | -1.0% | -11.3% | -39.8% | -52.9% | -20.7% | -2.3% | -5.0% | -14.2% | +19.9% | -1.7% | -6.7% | -3.1% |
Range-$1.55B – -$841.00M
CAGR-0.1%
Avg YoY Growth-4.5%
Median YoY Growth-4.0%
AOCI at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's aoci?
- Bristol-Myers Squibb (BMY) reported aoci of -$1.51B in Q3 2025.
- How has Bristol-Myers Squibb's aoci changed year-over-year?
- Bristol-Myers Squibb's aoci decreased by 3.1% year-over-year, from -$1.47B to -$1.51B.
- What is the long-term trend for Bristol-Myers Squibb's aoci?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's aoci has grown at a -9.4% compound annual growth rate (CAGR), from -$1.84B to -$1.24B.
- What does aoci mean?
- A bucket for 'paper' gains or losses on investments and currency changes that haven't been finalized yet.